These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 20215497
1. Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma. Grange C, Geninatti-Crich S, Esposito G, Alberti D, Tei L, Bussolati B, Aime S, Camussi G. Cancer Res; 2010 Mar 15; 70(6):2180-90. PubMed ID: 20215497 [Abstract] [Full Text] [Related]
2. Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. de Smet M, Langereis S, van den Bosch S, Grüll H. J Control Release; 2010 Apr 02; 143(1):120-7. PubMed ID: 19969035 [Abstract] [Full Text] [Related]
3. Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes. Paoli EE, Ingham ES, Zhang H, Mahakian LM, Fite BZ, Gagnon MK, Tam S, Kheirolomoom A, Cardiff RD, Ferrara KW. J Control Release; 2014 Mar 28; 178():108-17. PubMed ID: 24434424 [Abstract] [Full Text] [Related]
4. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma. Coukell AJ, Spencer CM. Drugs; 1997 Mar 28; 53(3):520-38. PubMed ID: 9074848 [Abstract] [Full Text] [Related]
5. Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study. de Smet M, Heijman E, Langereis S, Hijnen NM, Grüll H. J Control Release; 2011 Feb 28; 150(1):102-10. PubMed ID: 21059375 [Abstract] [Full Text] [Related]
8. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD. J Clin Pharmacol; 1996 Jan 28; 36(1):55-63. PubMed ID: 8932544 [Abstract] [Full Text] [Related]
9. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models. Gabizon A, Tzemach D, Gorin J, Mak L, Amitay Y, Shmeeda H, Zalipsky S. Cancer Chemother Pharmacol; 2010 May 28; 66(1):43-52. PubMed ID: 19779718 [Abstract] [Full Text] [Related]
10. Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin. Fite BZ, Kheirolomoom A, Foiret JL, Seo JW, Mahakian LM, Ingham ES, Tam SM, Borowsky AD, Curry FE, Ferrara KW. J Control Release; 2017 Jun 28; 256():203-213. PubMed ID: 28395970 [Abstract] [Full Text] [Related]
11. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice. Kato Y, Zhu W, Backer MV, Neoh CC, Hapuarachchige S, Sarkar SK, Backer JM, Artemov D. Pharm Res; 2015 Nov 28; 32(11):3746-3755. PubMed ID: 26078000 [Abstract] [Full Text] [Related]
12. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region. Amin M, Mansourian M, Koning GA, Badiee A, Jaafari MR, Ten Hagen TLM. J Control Release; 2015 Dec 28; 220(Pt A):308-315. PubMed ID: 26526970 [Abstract] [Full Text] [Related]
13. Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination. Fonseca NA, Gomes-da-Silva LC, Moura V, Simões S, Moreira JN. J Control Release; 2014 Dec 28; 196():122-31. PubMed ID: 25305563 [Abstract] [Full Text] [Related]
14. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors. Peller M, Willerding L, Limmer S, Hossann M, Dietrich O, Ingrisch M, Sroka R, Lindner LH. J Control Release; 2016 Sep 10; 237():138-46. PubMed ID: 27364227 [Abstract] [Full Text] [Related]
15. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma. Amantea MA, Forrest A, Northfelt DW, Mamelok R. Clin Pharmacol Ther; 1997 Mar 10; 61(3):301-11. PubMed ID: 9084455 [Abstract] [Full Text] [Related]
16. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. Park JH, Cho HJ, Yoon HY, Yoon IS, Ko SH, Shim JS, Cho JH, Park JH, Kim K, Kwon IC, Kim DD. J Control Release; 2014 Jan 28; 174():98-108. PubMed ID: 24280260 [Abstract] [Full Text] [Related]
17. Magnetic resonance guided high-intensity focused ultrasound mediated hyperthermia improves the intratumoral distribution of temperature-sensitive liposomal doxorubicin. de Smet M, Hijnen NM, Langereis S, Elevelt A, Heijman E, Dubois L, Lambin P, Grüll H. Invest Radiol; 2013 Jun 28; 48(6):395-405. PubMed ID: 23399809 [Abstract] [Full Text] [Related]
18. Local targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin. Zhao C, Feng Q, Dou Z, Yuan W, Sui C, Zhang X, Xia G, Sun H, Ma J. PLoS One; 2013 Jun 28; 8(9):e73860. PubMed ID: 24040096 [Abstract] [Full Text] [Related]
19. Porphyrin-phospholipid liposomes with tunable leakiness. Luo D, Carter KA, Razi A, Geng J, Shao S, Lin C, Ortega J, Lovell JF. J Control Release; 2015 Dec 28; 220(Pt A):484-494. PubMed ID: 26578438 [Abstract] [Full Text] [Related]
20. Human epidermal growth factor receptor-2 antibodies enhance the specificity and anticancer activity of light-sensitive doxorubicin-labeled liposomes. Li Q, Tang Q, Zhang P, Wang Z, Zhao T, Zhou J, Li H, Ding Q, Li W, Hu F, Du Y, Yuan H, Chen S, Gao J, Zhan J, You J. Biomaterials; 2015 Jul 28; 57():1-11. PubMed ID: 25956192 [Abstract] [Full Text] [Related] Page: [Next] [New Search]